Aldosterone and Treatment-Resistant Hypertension

  • Leopold, Jane A. M.D.
  • Ingelfinger, Julie R. M.D.

Disclosure forms are available with the full text of this editorial at NEJM.org.

New England Journal of Medicine 388(5):p 464-467, February 2, 2023. | DOI: 10.1056/NEJMe2213559

Decreasing the Effects of Aldosterone in Resistant Hypertension — A Success Story

  • Azizi, Michel M.D., Ph.D.
New England Journal of Medicine 388(5):p 461-463, February 2, 2023. | DOI: 10.1056/NEJMe2216143

Corresponding Article

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

  • Freeman, Mason W. M.D.
  • Halvorsen, Yuan-Di Ph.D.
  • Marshall, William M.D.
  • Pater, Mackenzie Ph.D.
  • Isaacsohn, Jon M.D.
  • Pearce, Catherine D.H.Sc.
  • Murphy, Brian M.D., M.P.H.
  • Alp, Nicholas M.D.
  • Srivastava, Ajay M.D.
  • Bhatt, Deepak L. M.D., M.P.H.
  • Brown, Morris J. M.D.
New England Journal of Medicine 388(5):p 395-405, February 2, 2023. | DOI: 10.1056/NEJMoa2213169
Copyright © 2023 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF